Get started
Author

Sarah Wexler

Observed names: S. A. Wexler, Sarah A Wexler, Sarah A. Wexler, Sarah Anne Wexler, Wexler, Sarah, Wexler, Sarah A.
ORCID: 0000-0002-0046-8725
Observed ORCID: 0000-0002-0046-8725
OpenAlex ID: A5019103263
Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not
2003 · Sarah A. Wexler, Craig Donaldson, et al. · British Journal of Haematology · 652
Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy
2010 · Kevin Kemp, Ruth Morse, et al. · Annals of Hematology · 63
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations
2024 · Nigel H. Russell, Charlotte Wilhelm-Benartzi, et al. · Journal of Clinical Oncology · 58
Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study
2024 · Nichola Cooper, Marie Scully, et al. · British Journal of Haematology · 28
PDF
Squamous Cell Carcinoma of the Conjunctiva Presenting With Intraocular Extension
1985 · S. A. Wexler, I. H. L. Wallow · Archives of Ophthalmology · 20
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial
2024 · Lise J Estcourt, Zoe K McQuilten, et al. · The Lancet Haematology · 17
Development of a structured process for fair allocation of critical care resources in the setting of insufficient capacity: a discussion paper
2020 · Tim Cook, Kim Gupta, et al. · Journal of Medical Ethics · 17
‘You’re kind of left to your own devices’: a qualitative focus group study of patients with breast, prostate or blood cancer at a hospital in the South West of England, exploring their engagement with exercise and physical activity during cancer treatment and in the months following standard care
2022 · Sian Karen Smith, Gareth Wiltshire, et al. · BMJ Open · 13
PDF
Primary mesenchymal stromal cells in co-culture with leukaemic HL-60 cells are sensitised to cytarabine-induced genotoxicity, while leukaemic cells are protected
2021 · Liana E Gynn, Elizabeth Anderson, et al. · Mutagenesis · 12
PDF
The experiences of cancer patients within the material hospital environment: Three ways that materiality is affective
2020 · Gareth Wiltshire, Emma Pullen, et al. · Social Science & Medicine · 11
Physicians Poster Abstracts: EBMT 2011
2011 · May, Jennifer E., Morse, Ruth, et al. · Bone Marrow Transplantation · 9
PDF
Tranexamic Acid to Prevent Bleeding in Patients with Hematologic Malignancies and Severe Thrombocytopenia (TREATT trial). a Randomized Placebo-Controlled Trial
2023 · Lise J Estcourt, Zoe K McQuilten, et al. · Blood · 3
A HaemSTAR-led, UK-wide 'flash-mob’ audit of intravenous immunoglobulin use in immune thrombocytopenia
2019 · Phillip Nicolson, Rita Perry, et al. · Clinical Medicine · 3
PDF
Abstracts of the 33rd Annual Meeting of the United Kingdom Environmental Mutagen society, 12th-14th July 2010 at the University of Derby, UK
2010 · May, Jennifer E., Morse, Ruth, et al. · Mutagenesis · 2
PDF
G CSF: A First Line Therapy for Autoimmune Neutropenia?
1997 · S. A. Wexler, S. H. Otton, et al. · Hematology · 2
PDF
Influence of Bone Marrow Stromal and Leukemic Cells on Cytarabine Chemo-Toxicity in Acute Myeloid Leukemia (AML)
2019 · Liana E Gynn, Elizabeth Anderson, et al. · Blood · 1
P81 Audit of HIV testing in a lymphoma clinic: Abstract P81 Table 1
2015 · Harriet LeVoir, Sarah Wexler, et al. · Sexually Transmitted Infections · 1
PDF
An in vitro model of chemotherapeutic damage to mesenchymal stem cells
2010 · Jennifer May, Jinsheng Xu, et al. · UWE Research Repository (UWE Bristol)
PDF
Modelling chemotherapeutic damage to mesenchymal stem cells
2010 · Jennifer May, Jinsheng Xu, et al. · UWE Research Repository (UWE Bristol)
Mesenchymal stem cell response to chemotherapeutic damage
2009 · Jennifer May, Jinsheng Xu, et al. · UWE Research Repository (UWE Bristol)
Reduced mesenchymal stem cell (MSC) proliferation and adhesion molecule expression in patients after chemotherapy for haematological malignancies
2006 · Kevin Kemp, Ruth Morse, et al. · Toxicology
Works count: 21
Citation count: 912
H-index: 10
I10-index: 10
Year
Topic
Type